NovoStent Corporation
NovoStent is a medical device company that has developed proprietary anchored helical stent platform to address variety of peripheral vasculatures. Their proprietary stent links a helical body to a radial anchor and provides superior flexibility and durability.
| Company | NovoStent Corporation |
|---|---|
| URL | http://www.NovoStent.com/ |
MOUNTAIN VIEW, Calif.—(BUSINESS WIRE)—March 31, 2008—NovoStent Corporation, a privately held medical device company, announced today that physicians in Germany have implanted 250 mm stents as part of the company's European clinical trial evaluating the use of NovoStent's peripheral stent in the treatment of superficial femoral and popliteal artery disease.
NovoStent Names G. Ray Martin, PhD, President & CEO
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE) -October 17, 2005--NovoStent Corporation, a medical device company that has developed a novel "anchored" helical stent technology to provide a wide range of vascular therapies, announced today that G. Ray...
06/17/2008 | Taro InabaBoehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
11/01/2007 | Nobuhiro Shimizu【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
07/18/2007 | Taro InabaMitsui Ventures Launching a New Approach to Seed Financing